Parkinson’s disease is characterized by four main phases: Parkinson’s syndrome (PDS), Parkinson’s neuromusculoskeletal syndrome (PMS), and Parkinson’s residuals. Each of these phases has many characteristics that can be shared with other disorders of motor function such as diabetes or Tourette’s syndrome. The four stages are: early, moderate, and advanced Parkinson’s.
Parkinson’s symptoms primarily affect the motor functions of the body, including but not limited to, walking, coordination, and balance. Common symptoms include tremors, slowing of movement, slowing of speech, and loss of balance and coordination. Parkinson’s disease symptoms will vary in their intensity from person to person. The majority of Parkinson’s symptoms can be treated using non-pharmaceutical methods, but some patients may require surgery, oral medications, or deep neurostimulation.
The first stage of Parkinson’s symptoms is relatively clear, whereby many people exhibit a decrease in their ability to both walk and talk. As the disease progresses, more specific clinical assessments begin to reveal subtle changes that are associated with each area of Parkinson’s symptoms. Because there is no cure for Parkinson’s, many people with the disorder often live with the disabling condition for their entire lives. Early diagnosis and treatment can help to dramatically reduce the number of disability-related problems experienced by sufferers.
The second phase of Parkinson’s disease is marked by gradual loss of motor abilities and function. This second stage of the disease can have a significant impact on quality of life, because it can often significantly limit the ability to engage in many daily tasks. Because this second stage of Parkinson’s affects the nerves controlling body movements, treatments aimed at controlling muscle spasms and abnormal gait are particularly effective. In addition, medications that treat symptoms of this stage can also help control movement. Many physicians rely heavily on dopamine D2 receptor antagonists to treat patients with Parkinson’s.
The third stage of Parkinson’s symptoms involves the development of rigidity of the limbs. With rigidity of the limb comes severe bracing of the movement, which can result in a loss of balance and walking. Because these symptoms are most commonly found in Parkinson’s disease patients who have already lost the ability to move on their own, doctors usually place patients on dopamine D2 receptor blockers to help them maintain a balanced gait. Claudication, or difficulty with walking, can also develop as a side effect of some medications used to treat Parkinson’s, so patients are closely monitored when undergoing any type of treatment.
Other medications used to treat Parkinson’s include levodopa or loratadine. Levodopa, which is sometimes marketed under the name Permanently relieving hyperactivity, has been known to produce a reduction in involuntary movements of people suffering from Parkinson’s. While levodopa does produce measurable effects on the brain, the impact is not permanent. The body will eventually need to produce dopamine on its own, and this is why it is often prescribed in conjunction with the dopamine-lowering medication Lidocaine.
The fourth stage of Parkinson’s symptoms is primarily a result of motor symptoms. With levodopa, an excess of the hormone levodopa can build up in the body. This eventually causes the muscle fibers to grow abnormally. In addition, the nerve cells affected by levodopa damage significantly. When this occurs, the ability to coordinate and maintain muscle movement becomes increasingly difficult, making it possible for Parkinson’s symptoms to progress.
Parkinson’s symptoms may include one side of the body losing muscle coordination, while other parts of the body remain able to function normally. Although not all cases involve one side or the other, more than 90 percent of sufferers report that both hemiplegia (loss of leg movement) and hemiparesis (lack of limb movement) occur on one side of the body only. Additionally, motor symptoms may include wobbling, rigidity, or slow movements, while facial movements may be sparse or nonexistent. In extreme cases, both hemiplegia and hemiparesis can affect one side of the body only.
Oren Zarif – Psychokinesis Treatment
